← Back to all earnings calls

Day One Biopharmaceuticals, Inc. Q2 FY2024 Earnings Call

Day One Biopharmaceuticals, Inc. (DAWN)

Earnings Call FY2024 Q2 Call date: 2024-07-30 Concluded

Share

Quarter scorecard

Revenue

$8.19M

Diluted EPS

$-0.05

Net income

-$4.41M

Revenue · products & services

Product $8.19M

License $0

Documents & deck